146 related articles for article (PubMed ID: 34090932)
21. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Wang Y; Li D; Liu Y; Tian S; Chen X
Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.
Khumukcham SS; Samanthapudi VSK; Penugurti V; Kumari A; Kesavan PS; Velatooru LR; Kotla SR; Mazumder A; Manavathi B
J Biol Chem; 2019 Jun; 294(26):10236-10252. PubMed ID: 31101654
[TBL] [Abstract][Full Text] [Related]
23. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA.
Abramovich C; Shen WF; Pineault N; Imren S; Montpetit B; Largman C; Humphries RK
J Biol Chem; 2000 Aug; 275(34):26172-7. PubMed ID: 10825160
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
[TBL] [Abstract][Full Text] [Related]
25. HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
Chen B; Zhao J; Zhang S; Zhang Y; Huang Z
Oncol Rep; 2016 Dec; 36(6):3664-3672. PubMed ID: 27748944
[TBL] [Abstract][Full Text] [Related]
26. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
27. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
Xu X; Jiang C; Wang S; Tai Y; Wang T; Kang L; Fan Z; Li S; Li L; Fu J; Liu J; Ji Q; Wang X; Wei L; Ye Q
IUBMB Life; 2013 Oct; 65(10):873-82. PubMed ID: 24038948
[TBL] [Abstract][Full Text] [Related]
28. miR‑152 regulates TGF‑β1‑induced epithelial‑mesenchymal transition by targeting HPIP in tubular epithelial cells.
Ning YX; Wang XY; Wang JQ; Zeng R; Wang GQ
Mol Med Rep; 2018 Jun; 17(6):7973-7979. PubMed ID: 29620271
[TBL] [Abstract][Full Text] [Related]
29. The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway.
Mai H; Xu X; Mei G; Hong T; Huang J; Wang T; Yan Z; Li Y; Liang Y; Li L; Jin S; You W; Ma Y; Chen L; Ye Q
Oncogenesis; 2016 Oct; 5(10):e260. PubMed ID: 27694835
[TBL] [Abstract][Full Text] [Related]
30. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
31. CSR1 suppresses tumor growth and metastasis of human hepatocellular carcinoma via inhibition of HPIP.
Jiang L; Hu G; Chen FF; Du XY; Liu B; Liu C
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3813-3820. PubMed ID: 28975986
[TBL] [Abstract][Full Text] [Related]
32. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
33. An inherent role of microtubule network in the action of nuclear receptor.
Manavathi B; Acconcia F; Rayala SK; Kumar R
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15981-6. PubMed ID: 17043237
[TBL] [Abstract][Full Text] [Related]
34. HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways.
Penugurti V; Khumukcham SS; Padala C; Dwivedi A; Kamireddy KR; Mukta S; Bhopal T; Manavathi B
Cancer Lett; 2021 Oct; 518():243-255. PubMed ID: 34302919
[TBL] [Abstract][Full Text] [Related]
35. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic PBX-Interaction Protein Promotes Breast Cancer Sensitivity to Paclitaxel Through a Microtubule-Dependent Mechanism.
Yu B; Tian X; Zhang L; Feng R
DNA Cell Biol; 2016 Nov; 35(11):740-745. PubMed ID: 27754697
[TBL] [Abstract][Full Text] [Related]
37. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
[TBL] [Abstract][Full Text] [Related]
38. TEX11 modulates germ cell proliferation by competing with estrogen receptor β for the binding to HPIP.
Yu YH; Siao FP; Hsu LC; Yen PH
Mol Endocrinol; 2012 Apr; 26(4):630-42. PubMed ID: 22383461
[TBL] [Abstract][Full Text] [Related]
39. Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration.
van Vuurden DG; Aronica E; Hulleman E; Wedekind LE; Biesmans D; Malekzadeh A; Bugiani M; Geerts D; Noske DP; Vandertop WP; Kaspers GJ; Cloos J; Würdinger T; van der Stoop PP
Neuro Oncol; 2014 Jul; 16(7):946-59. PubMed ID: 24470547
[TBL] [Abstract][Full Text] [Related]
40. HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.
Jiang Q; Zhang D; Liu J; Liang C; Yang R; Zhang C; Wu J; Lin J; Ye T; Ding L; Li J; Gao S; Li B; Ye Q
Sci Adv; 2023 Jun; 9(23):eade1155. PubMed ID: 37294756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
